iifl-logo

Suven Life Sciences Ltd Share Price Live

Add as a Preferred Source on Google
₹320.2
(-1.40%)
Sep 30, 2026|03:59:59 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Equities

Futures

Option

  • Open₹326
  • Day's High₹328.5
  • 52 Wk High₹403.35
  • Prev. Close₹324.75
  • Day's Low₹315.6
  • 52 Wk Low ₹124.11
  • Turnover (lac)1,289.32
  • P/E0
  • Face Value₹1
  • Book Value₹55.94
  • EPS0
  • Mkt. Cap (Cr.)₹9,047.66
  • Div. Yield0
View All Historical Data

No Record Found

No Record Found

Suven Life Sciences Ltd KEY RATIOS

Sector

Healthcare

Open

₹326

Prev. Close

₹324.75

Turnover(Lac.)

₹1,289.32

Day's High

₹328.5

Day's Low

₹315.6

52 Week's High

₹403.35

52 Week's Low

₹124.11

Book Value

₹55.94

Face Value

₹1

Mkt Cap (₹ Cr.)

9,047.66

P/E

0

EPS

0

Divi. Yield

0

Suven Life Sciences Ltd Corporate Action

13 May 2026

12:00 AM

AGM

Announcement Date: 13 May, 2026

arrow

30 Jul 2026

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

13 May 2025

12:00 AM

EGM

arrow

Suven Life Sciences Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Suven Life Sciences Ltd SHAREHOLDING SNAPSHOT

30 Sep, 2026|08:27 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 65.47%

Foreign: 0.00%

Indian: 65.47%

Non-Promoter- 3.21%

Institutions: 3.21%

Non-Institutions: 31.31%

Custodian: 0.00%

Share PriceShare Price

Suven Life Sciences Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2026Mar-2025Mar-2024Mar-2023

Equity Capital

181.89

21.81

21.81

21.81

Preference Capital

0

0

0

0

Reserves

1,321.47

777.7

823.57

831.64

Net Worth

1,503.36

799.51

845.38

853.45

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

11.84

13.47

14.41

625.25

yoy growth (%)

-12.12

-6.49

-97.69

15.03

Raw materials

0

0

0

-153.7

As % of sales

0

0

0

24.58

Employee costs

-17.46

-15.28

-14.59

-58.73

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

-36.24

-27.95

-25.93

230.26

Depreciation

-4.39

-4.34

-4.16

-21.3

Tax paid

0

5.32

12.18

-71.83

Working capital

-73.46

43.42

-154.2

81.51

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

-12.12

-6.49

-97.69

15.03

Op profit growth

19.95

-13.37

-115.13

40.86

EBIT growth

31.61

6.86

-110.81

42.32

Net profit growth

60.16

64.55

-108.68

28.3

View Ratios
Particulars (Rupees in Crores.)Mar-2026Mar-2025Mar-2024Mar-2023Mar-2022

Gross Sales

7.11

6.66

11.69

13.54

11.84

Excise Duty

0

0

0

0

0

Net Sales

7.11

6.66

11.69

13.54

11.84

Other Operating Income

0

0

0

0

0

Other Income

13.93

10.9

28.59

14.45

5.32

Suven Life Sciences Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

8,659

79.21,25,119.97385.20.232,656.1692.92

Manipal Health Enterprises Ltd

MANIPALHOS

747.75

471.0198,508.6115.5301,048.365.9

Max Healthcare Institute Ltd

MAXHEALTH

982.1

131.0295,768.86167.60.2782.9291.83

Aster DM Quality Care Ltd

ASTERDM

733.95

207.1364,094.07-14.30.24725.7349.23

Fortis Healthcare Ltd

FORTIS

822

310.2361,831.0747.780.12489.45122.24

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Suven Life Sciences Ltd

Management

Register Office

Registrar Office

Chairman / Executive Director / M D / Promoter

Venkateswarlu Jasti

WTD & Executive Director

Sudha Rani Jasti

Non Executive Director

Seyed E Hasnain

Independent Non Exe. Director

Santanu Mukherjee

Independent Non Exe. Director

J A S Padmaja

Independent Non Exe. Director

Vajja Sambasiva Rao

Company Sec. & Compli. Officer

K Sangeetha Laxmi

Registered Office

#8-2-334 SDE Serene Chambers,

6 th Floor Road No 5 Avenue 7,

Telangana - 500034

Tel: 91-40-23541142/3311/3315

Website: http://www.suven.com

Email: info@suven.com; investorservices@suven.com

Registrar Office

Karvy Selenium Tow-B,

31&32 Financial Dist, Nanakramguda,

Hyderabad-500032

Tel: 91-40-67162222

Website: www.kfintech.com

Email: einward.ris@karvy.com

Summary

Suven Life Sciences Limited was initially established as Suven Pharmaceuticals Limited in March, 1989 and changed to the present name in September 2003. The Company is a clinical-stage biopharma compa...
Read More

Company FAQs

The Suven Life Sciences Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹320.2 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Suven Life Sciences Ltd is ₹9047.66 Cr. as of 30 Sep ‘26
The PE and PB ratios of Suven Life Sciences Ltd is 0 and 5.76 as of 30 Sep ‘26
The 52-week high/low is the highest and lowest price at which a Suven Life Sciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Suven Life Sciences Ltd is ₹124.11 and ₹403.35 as of 30 Sep ‘26
Suven Life Sciences Ltd's CAGR for 5 Years at 30.66%, 3 Years at 65.96%, 1 Year at 60.96%, 6 Month at 146.58%, 3 Month at 17.24% and 1 Month at -17.17%.
The shareholding pattern of Suven Life Sciences Ltd is as follows:
Promoters - 65.47 %
Institutions - 3.21 %
Public - 31.32 %
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.